These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 1970504)

  • 1. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.
    Masuo Y; Montagne MN; Pélaprat D; Scherman D; Rostène W
    Brain Res; 1990 Jun; 520(1-2):6-13. PubMed ID: 2169955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
    Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U
    Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum.
    Masuo Y; Pélaprat D; Scherman D; Rostène W
    Neurosci Lett; 1990 Jun; 114(1):45-50. PubMed ID: 1974339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
    Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR
    Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C; Slevin JT
    Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal dopamine levels after unilateral lesions of the substantia nigra: evidence for a contralateral decrease.
    Hahn Z; Karádi Z; Lénárd L
    Acta Physiol Acad Sci Hung; 1981; 57(3):249-53. PubMed ID: 6795897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat.
    Savasta M; Dubois A; Benavides J; Scatton B
    Neurosci Lett; 1986 Dec; 72(3):265-71. PubMed ID: 2950341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the unilateral striatal lesion on neurotransmitter markers in the contralateral striatum and both substantia nigrae of the rat.
    Masuo Y; Kanazawa I
    Neuroscience; 1988 Dec; 27(3):827-36. PubMed ID: 2908058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.
    Taylor MD; De Ceballos ML; Rose S; Jenner P; Marsden CD
    Eur J Pharmacol; 1992 Aug; 219(2):183-92. PubMed ID: 1385171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons.
    Beckstead RM
    Neuroscience; 1988 Dec; 27(3):851-63. PubMed ID: 3150855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotensin regulation of endogenous acetylcholine release from rat striatal slices is independent of dopaminergic tone.
    Lapchak PA; Araujo DM; Quirion R; Beaudet A
    J Neurochem; 1991 Feb; 56(2):651-7. PubMed ID: 1899109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
    Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B
    Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of the amount of neurotensin retrogradely transported in dopaminergic neurons of senescent rats.
    Castel MN; Lechardeur D; Blanchard JC; Laduron PM
    Neurosci Lett; 1991 Mar; 124(1):111-4. PubMed ID: 1713313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral modulation of [3H]neurotensin binding by unilateral intrastriatal 6-hydroxydopamine injections: evidence from a receptor autoradiographic study.
    Cadet JL; Kujirai K; Przedborski S
    Brain Res; 1991 Nov; 564(1):37-44. PubMed ID: 1663814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
    Merchant KM; Bush LG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra.
    Smith JA; Leslie FM; Broide RS; Loughlin SE
    Neuroscience; 1993 Aug; 55(4):935-51. PubMed ID: 8232904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiographic evidence for the localization of high affinity neurotensin binding sites on dopaminergic nerve terminals in the nigrostriatal and mesolimbic pathways in rat brain.
    Schotte A; Leysen JE
    J Chem Neuroanat; 1989; 2(5):253-7. PubMed ID: 2553068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.